High risks for breast and ovarian cancers. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Breast Cell Line, Tumor Tumor Cells, Cultured Ovary Neoplastic Stem Cells Epithelial Cells MCF-7 Cells Mammary Glands, Human Nipples Axilla Lymph Nodes

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases53

Ovarian Neoplasms Neoplasms, Glandular and Epithelial Carcinoma, Ductal, Breast Breast Diseases Cystadenocarcinoma, Serous Neoplasm Invasiveness Carcinoma Breast Neoplasms Neoplasm Metastasis Genetic Predisposition to Disease Breast Neoplasms, Male Adenocarcinoma, Clear Cell Neoplasm Recurrence, Local Neoplasms Prostatic Neoplasms Adenocarcinoma, Mucinous Lung Neoplasms Disease Progression Carcinoma, Endometrioid Peritoneal Neoplasms Ascites Colonic Neoplasms Fibrocystic Breast Disease Stomach Neoplasms Endometrial Neoplasms Carcinoma, Intraductal, Noninfiltrating Cystadenocarcinoma Uterine Cervical Neoplasms Carcinoma, Lobular Pancreatic Neoplasms Cell Transformation, Neoplastic Adenocarcinoma Fallopian Tube Neoplasms Hereditary Breast and Ovarian Cancer Syndrome Neoplasms, Hormone-Dependent Colorectal Neoplasms Neovascularization, Pathologic Neoplastic Syndromes, Hereditary Mammary Neoplasms, Experimental Neoplasms, Cystic, Mucinous, and Serous Genital Neoplasms, Female Carcinoma, Squamous Cell Neoplasms, Second Primary Urinary Bladder Neoplasms Carcinoma in Situ Carcinoma, Non-Small-Cell Lung Neoplasms, Multiple Primary Cystadenocarcinoma, Mucinous Lymphatic Metastasis Bone Neoplasms Precancerous Conditions Rectal Neoplasms Cystadenoma, Serous

Chemicals and Drugs53

CA-125 Antigen Tumor Markers, Biological Antineoplastic Agents Receptors, Estrogen BRCA2 Protein Neoplasm Proteins BRCA1 Protein Receptor, erbB-2 Cisplatin Receptors, Progesterone Paclitaxel Tamoxifen RNA, Messenger DNA, Neoplasm Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal RNA, Small Interfering Carboplatin Tumor Suppressor Protein p53 Epididymal Secretory Proteins Antigens, Neoplasm Cancer Vaccines Estrogens Antibodies, Monoclonal Taxoids Estrogen Receptor alpha RNA, Neoplasm Tumor Suppressor Proteins Transcription Factors Platinum Compounds Receptor, Epidermal Growth Factor Antibodies, Monoclonal, Humanized Fluorouracil Platinum MicroRNAs Cyclophosphamide DNA-Binding Proteins Antigens, Tumor-Associated, Carbohydrate Mucin-1 Topotecan Proto-Oncogene Proteins c-akt Anticarcinogenic Agents Ki-67 Antigen Contraceptives, Oral Nuclear Proteins Estrogen Antagonists Proto-Oncogene Proteins Antibiotics, Antineoplastic Estradiol Aromatase Inhibitors Deoxycytidine Prostate-Specific Antigen DNA Primers

Analytical, Diagnostic and Therapeutic Techniques and Equipment73

Prognosis Risk Factors Early Detection of Cancer Neoplasm Staging Survival Analysis Antineoplastic Combined Chemotherapy Protocols Mammography Risk Survival Rate Risk Assessment Prospective Studies Follow-Up Studies Reverse Transcriptase Polymerase Chain Reaction Disease-Free Survival Gene Expression Profiling Retrospective Studies Xenograft Model Antitumor Assays Immunohistochemistry Case-Control Studies Treatment Outcome Sensitivity and Specificity Odds Ratio Blotting, Western Chemotherapy, Adjuvant Mastectomy Incidence Genetic Testing Neoplasm Transplantation Multivariate Analysis Cohort Studies Breast Self-Examination Registries Predictive Value of Tests Kaplan-Meier Estimate Oligonucleotide Array Sequence Analysis Transplantation, Heterologous Tissue Array Analysis Breast Implants Polymerase Chain Reaction Logistic Models Questionnaires Reproducibility of Results Neoplasm Grading Tumor Burden Drug Screening Assays, Antitumor Transfection Combined Modality Therapy Drug Administration Schedule Confidence Intervals Mammary Neoplasms, Experimental Immunoenzyme Techniques SEER Program DNA Mutational Analysis Clinical Trials as Topic Mass Screening Ultrasonography, Mammary Gene Knockdown Techniques Mastectomy, Segmental Molecular Targeted Therapy Proportional Hazards Models Biopsy Models, Biological Biopsy, Needle Mammaplasty Enzyme-Linked Immunosorbent Assay Reproductive History Salpingectomy Radiotherapy, Adjuvant Radiotherapy ROC Curve Flow Cytometry Ovariectomy Pedigree

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Smoking

Phenomena and Processes50

Genes, BRCA1 Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Genes, BRCA2 Breast Feeding Genetic Predisposition to Disease Risk Cell Proliferation Germ-Line Mutation Mutation Sensitivity and Specificity Apoptosis Odds Ratio Postmenopause Time Factors DNA Methylation Signal Transduction Genotype Cell Movement Cell Division Down-Regulation Menopause Cell Growth Processes Premenopause Dose-Response Relationship, Drug Up-Regulation Polymorphism, Genetic Transfection Genes, Tumor Suppressor Cell Cycle Promoter Regions, Genetic Cell Survival RNA Interference Heterozygote Gene Silencing Gene Expression Parity Genes, erbB-2 Base Sequence Gene Amplification Genes, Neoplasm Phenotype Genes, p53 Alleles Drug Synergism Loss of Heterozygosity Phosphorylation Diet Epithelial-Mesenchymal Transition Tumor Microenvironment

Disciplines and Occupations3

Immunohistochemistry Genetic Counseling Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries Questionnaires SEER Program Base Sequence Molecular Sequence Data

Named Groups3

Survivors Jews European Continental Ancestry Group

Health Care36

Risk Factors Survival Analysis Risk Survival Rate Risk Assessment Prospective Studies Follow-Up Studies Disease-Free Survival Retrospective Studies Case-Control Studies Treatment Outcome Sensitivity and Specificity Age Factors Odds Ratio Incidence Genetic Testing Multivariate Analysis Cohort Studies Registries Predictive Value of Tests Kaplan-Meier Estimate Logistic Models Questionnaires Reproducibility of Results Confidence Intervals SEER Program Clinical Trials as Topic Mass Screening Genetic Counseling Parity National Cancer Institute (U.S.)Family Health Proportional Hazards Models Reproductive History Age of Onset ROC Curve

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Breast Neoplasms, Glandular and Epithelial Carcinoma, Ductal, Breast Cell Line, Tumor Breast Diseases Genes, BRCA1 CA-125 Antigen Cystadenocarcinoma, Serous Gene Expression Regulation, Neoplastic Tumor Markers, Biological Prognosis Neoplasm Invasiveness Risk Factors Carcinoma Early Detection of Cancer Antineoplastic Agents Neoplasm Staging Drug Resistance, Neoplasm Genes, BRCA2 Receptors, Estrogen Mice, Nude Breast Neoplasms Neoplasm Metastasis BRCA2 Protein Neoplasm Proteins Breast Feeding BRCA1 Protein Genetic Predisposition to Disease Breast Neoplasms, Male Receptor, erbB-2 Survival Analysis Antineoplastic Combined Chemotherapy Protocols Mammography Risk Cisplatin Tumor Cells, Cultured Survival Rate Adenocarcinoma, Clear Cell Risk Assessment Receptors, Progesterone Prospective Studies Follow-Up Studies Reverse Transcriptase Polymerase Chain Reaction Paclitaxel Disease-Free Survival Neoplasm Recurrence, Local Neoplasms Prostatic Neoplasms Tamoxifen Gene Expression Profiling Retrospective Studies Cell Proliferation Xenograft Model Antitumor Assays Immunohistochemistry Adenocarcinoma, Mucinous Lung Neoplasms Disease Progression Carcinoma, Endometrioid Case-Control Studies Germ-Line Mutation RNA, Messenger Mutation Peritoneal Neoplasms Treatment Outcome Ascites Sensitivity and Specificity DNA, Neoplasm Age Factors Antineoplastic Agents, Phytogenic Apoptosis Colonic Neoplasms Odds Ratio Blotting, Western Chemotherapy, Adjuvant Mastectomy Incidence Fibrocystic Breast Disease Antineoplastic Agents, Hormonal Genetic Testing Stomach Neoplasms RNA, Small Interfering Neoplasm Transplantation United States Multivariate Analysis Cohort Studies Breast Self-Examination Carboplatin Postmenopause Endometrial Neoplasms Registries Predictive Value of Tests Kaplan-Meier Estimate Carcinoma, Intraductal, Noninfiltrating Time Factors Oligonucleotide Array Sequence Analysis Transplantation, Heterologous Tumor Suppressor Protein p53 DNA Methylation Signal Transduction

No FAQ available that match "high risks for breast and ovarian cancers"